Philip Ly (BBMed (Hons)) is a Research Assistant experienced in conducting cancer clinical trials and implementing qualitative research methods. Philip is currently working on several projects across the Melanoma and Skin Cancer and Genomics and Precision Health streams at the Daffodil Centre. These projects include the Australian Cancer Risk Study, a program on genomic risk prediction and risk-tailored screening and early detection for the four most common cancers in Australia (breast, colorectal, melanoma and prostate); reviews in areas of cancer survivorship; and a randomised controlled trial of a personalised skin cancer prevention strategy among people with a history of skin cancer.
